The use of tumor necrosis factor-α; (TNF-α;) inhibitors in the treatment of various inflammatory conditions has altered the field of medical therapeutics. Squamous cell carcinoma is the second most common cancer of the skin, usually affecting sun-exposed areas of the body. We present here the case of a 75-year-old woman with rheumatoid arthritis, who developed an intertoe squamous cell carcinoma (SCC) of the right foot. According to her history, she received etanercept and methotrexate for 5 years for rheumatoid arthritis. The rare localization of this cancer could suggest a possible linkage of the malignancy to the chronic intake of anti-TNF-α; treatment. This is the first reported case of an interdigital SCC developed under the use of an anti-TNF-α; agent.
CITATION STYLE
Rallis, E., Bournia, V. K., Verros, C., & Iliopoulos, A. (2015). Intertoe squamous cell carcinoma developed in a patient with rheumatoid arthritis under etanercept therapy. Case Reports in Medicine, 2015. https://doi.org/10.1155/2015/315490
Mendeley helps you to discover research relevant for your work.